Reinforced stapler versus ultrasonic dissector for pancreatic transection and stump closure for distal pancreatectomy: A propensity matched analysis.


Journal

Surgery
ISSN: 1532-7361
Titre abrégé: Surgery
Pays: United States
ID NLM: 0417347

Informations de publication

Date de publication:
09 2019
Historique:
received: 17 12 2018
revised: 12 02 2019
accepted: 15 02 2019
pubmed: 13 4 2019
medline: 21 1 2020
entrez: 13 4 2019
Statut: ppublish

Résumé

Postoperative pancreatic fistula is the primary contributor to morbidity after distal pancreatectomy. To date, no techniques used for the transection and closure of the pancreatic stump have shown clear superiority over the others. This study aimed to compare the rate of postoperative pancreatic fistula after pancreatic transection conducted with a reinforced stapler versus an ultrasonic dissector after a distal pancreatectomy. Prospectively collected data of consecutive patients who underwent distal pancreatectomy from 2014 to 2017 were reviewed retrospectively. We included distal pancreatectomies in which pancreatic transection was performed by reinforced stapler or ultrasonic dissector; we excluded extended distal pancreatectomies. To overcome the absence of randomization, we conducted a propensity matching analysis according to risk factors for postoperative pancreatic fistula. Overall, 200 patients met the inclusion criteria. The reinforced stapler was employed in 108 patients and the ultrasonic dissector in 92 cases. After one-to-one propensity matching, 92 patients were selected from each group. The matched reinforced stapler and ultrasonic dissector cohort had no differences in baselines characteristics except for the mini-invasive approach, which was more common in the ultrasonic dissector group (34% vs 51%, P = .025). Overall, 48 patients (26%) developed a postoperative pancreatic fistula, 46 (25%) a grade B postoperative pancreatic fistula, and 2 (1%) a grade C postoperative pancreatic fistula. In the reinforced stapler group, the rate of postoperative pancreatic fistula was 12% (n = 11) and in the ultrasonic dissector group 40% (n = 37) with a P < .001. The results of this study suggest that the use of reinforced stapler for pancreatic transection decreases the risk of postoperative pancreatic fistula. A randomized trial is required to confirm these preliminary data.

Sections du résumé

BACKGROUND
Postoperative pancreatic fistula is the primary contributor to morbidity after distal pancreatectomy. To date, no techniques used for the transection and closure of the pancreatic stump have shown clear superiority over the others. This study aimed to compare the rate of postoperative pancreatic fistula after pancreatic transection conducted with a reinforced stapler versus an ultrasonic dissector after a distal pancreatectomy.
METHOD
Prospectively collected data of consecutive patients who underwent distal pancreatectomy from 2014 to 2017 were reviewed retrospectively. We included distal pancreatectomies in which pancreatic transection was performed by reinforced stapler or ultrasonic dissector; we excluded extended distal pancreatectomies. To overcome the absence of randomization, we conducted a propensity matching analysis according to risk factors for postoperative pancreatic fistula.
RESULTS
Overall, 200 patients met the inclusion criteria. The reinforced stapler was employed in 108 patients and the ultrasonic dissector in 92 cases. After one-to-one propensity matching, 92 patients were selected from each group. The matched reinforced stapler and ultrasonic dissector cohort had no differences in baselines characteristics except for the mini-invasive approach, which was more common in the ultrasonic dissector group (34% vs 51%, P = .025). Overall, 48 patients (26%) developed a postoperative pancreatic fistula, 46 (25%) a grade B postoperative pancreatic fistula, and 2 (1%) a grade C postoperative pancreatic fistula. In the reinforced stapler group, the rate of postoperative pancreatic fistula was 12% (n = 11) and in the ultrasonic dissector group 40% (n = 37) with a P < .001.
CONCLUSION
The results of this study suggest that the use of reinforced stapler for pancreatic transection decreases the risk of postoperative pancreatic fistula. A randomized trial is required to confirm these preliminary data.

Identifiants

pubmed: 30975498
pii: S0039-6060(19)30108-4
doi: 10.1016/j.surg.2019.02.016
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

271-276

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Alessandra Pulvirenti (A)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Luca Landoni (L)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Alex Borin (A)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Matteo De Pastena (M)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Martina Fontana (M)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Antonio Pea (A)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Alessandro Esposito (A)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Luca Casetti (L)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Massimiliano Tuveri (M)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Salvatore Paiella (S)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Giovanni Marchegiani (G)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Giuseppe Malleo (G)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Roberto Salvia (R)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy. Electronic address: Roberto.salvia@univr.it.

Claudio Bassi (C)

Unit of General and Pancreatic Surgery, University of Verona Hospital Trust, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH